Foamix Pharmaceuticals Ltd. Interest Expense on Debt
Foamix Pharmaceuticals Ltd. reported Interest Expense on Debt of $802.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. interest expense, debt for the quarter ending 2019-09-30 was $289.00K.
- Foamix Pharmaceuticals Ltd. interest expense, debt for fiscal 2019 was $802.00K.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 12 month |
|---|---|---|
| 2019-12-31 | $802.00K 10-K · filed 2020-03-12 | |
| 2019-09-30 | $289.00K 10-Q · filed 2019-11-12 |